Clinicopathological Significance of SMAD4 Expression in Breast Cancer

키워드

참고문헌 (29)

1. Siegel RL, "Colorectal cancer statistics, 2017", CA Cancer J Clin, 67, pp.177~193 (2017)
2. Guo F, "Trends in breast cancer mortality by stage at diagnosis among young women in the United States", Cancer, 124, pp.3500~3509 (2018)
3. Fayanju OM, "Molecular genomic testing for breast cancer: utility for surgeons", Ann Surg Oncol, 25, pp.512~519 (2018)
4. Heldin CH, "TGF-beta signalling from cell membrane to nucleus through SMAD proteins", Nature, 390, pp.465~471 (1997)
5. Miyaki M, "Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis", Oncogene, 18, pp.3098~3103 (1999)
6. Shi Y, "A structural basis for mutational inactivation of the tumour suppressor Smad4", Nature, 388, pp.87~93 (1997)
7. Yan P, "Reduced expression of SMAD4 is associated with poor survival in colon cancer", Clin Cancer Res, 22, pp.3037~3047 (2016)
8. Singh P, "SMAD4 genetic alterations predict a worse prognosis in patients with pancreatic ductal adenocarcinoma", Pancreas, 41, pp.541~546 (2012)
9. Singhi AD, "Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival", Am J Surg Pathol, 39, pp.487~495 (2015)
10. Min KW, "Expression pattern of Smad4", GATA3 as a predictor of survival in invasive ductal carcinoma of the breast, 2017, pp.84, 130~138
11. Stuelten CH, "Smad4-expression is decreased in breast cancer tissues: a retrospective study", BMC Cancer, 6, pp.25~ (2006)
12. De Kruijf EM, "The prognostic role of TGF-beta signaling pathway in breast cancer patients", Ann Oncol, 24, pp.384~390 (2013)
13. Liu N, "SMAD4 expression in breast ductal carcinoma correlates with prognosis", Oncol Lett, 10, pp.1709~1715 (2015)
14. Harvey JM, "Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer", J Clin Oncol, 17, pp.1474~1481 (1999)
15. Wolff AC, "American Society of Clinical Oncology", College of american pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer, 2007, pp.131, 18~43
16. Brown RS, "Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study", Cancer, 72, pp.2979~2985 (1993)
17. Remmele W, "Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue", Pathologe, 8, pp.138~140 (1987)
18. Wilentz RE, "Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation", Am J Pathol, 156, pp.37~43 (2000)
19. Wilentz RE, "Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression", Cancer Res, 60, pp.2002~2006 (2000)
20. Natsugoe S, "Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus", Clin Cancer Res, 8, pp.1838~1842 (2002)
21. Cardillo MR, "Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma", Anal Quant Cytol Histol, 23, pp.109~117 (2001)
22. Papageorgis P, "Smad4 inactivation promotes malignancy and drug resistance of colon cancer", Cancer Res, 71, pp.998~1008 (2011)
23. Blackford A, "SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer", Clin Cancer Res, 15, pp.4674~4679 (2009)
24. Ke Z, "Deleted in pancreatic carcinoma locus 4", Smad4 participates in the regulation of apoptosis by affecting the Bcl-2, Hum Pathol, pp.2008, 39[DOI]
25. Xie W, "Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study", Cancer Res, 62, pp.497~505 (2002)
26. Zugmaier G, "Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines", J Cell Physiol, 141, pp.353~361 (1989)
27. Gobbi H, "Transforming growth factor-β and breast cancer risk in women with mammary epithelial hyperplasia", J Natl Cancer Inst, 91, pp.2096~2101 (1999)
28. Wiercinska E, "The TGF-beta", Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system, 2011, pp.128, 657~666
29. Ronnov-Jessen L, "Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia", Lab Invest, 68, pp.696~707 (1993)

관련 논문AI추천